Shares of Vanda Pharmaceuticals, the makers of Fanapt (iloperidone), surged today after the U.S. Food and Drug Administration sprang a surprise drug approval for Fanapt for schizophrenia late yesterday.
In afternoon trading today, the stock hit $10.00 a share, over 8 times what the stock was …
Before posting, please read our blog moderation guidelines. The comments below begin with the oldest comments first. Click on the last comments page to jump to the most recent comments.
Before posting, please read our blog moderation guidelines.
Post a Comment:
Copyright © 1995-2013 Psych Central. All rights reserved.
Site last updated: 18 Jun 2013
|
This is one psychiatrist who will wait at least 6 months or more until I even think about prescribing this drug after all the consequences with the predecessors of this class. I don’t know much at all about it and will not have the reps provide the education, bet on that!
Sounds like a cousin of Risperdal, which is risperidone generically, and by the way, one of the atypicals I do have a little comfort in prescribing where warranted; certainly NOT as an antidepressant or anxiolytic though!!!
As an aside, read an earlier post where you were a bit critical of your colleagues gunning for prescribing habits. Good for you for not supporting this cause.